Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis

BACKGROUND: There remains a critical need for more effective, safe, long-term treatments for cystic fibrosis (CF). Any successful therapeutic strategy designed to combat the respiratory pathology of this condition must address the altered lung physiology and recurrent, complex, polymicrobial infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Charrier, Cedric, Rodger, Catherine, Robertson, Jennifer, Kowalczuk, Aleksandra, Shand, Nicola, Fraser-Pitt, Douglas, Mercer, Derry, O’Neil, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260250/
https://www.ncbi.nlm.nih.gov/pubmed/25433388
http://dx.doi.org/10.1186/s13023-014-0189-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260250/
https://www.ncbi.nlm.nih.gov/pubmed/25433388
http://dx.doi.org/10.1186/s13023-014-0189-2

Ejemplares similares